Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Inhaled nitric oxide in preterm infants: a systematic review.

Pamela K Donohue1, Maureen M Gilmore, Elizabeth Cristofalo

  • 1Department of Pediatrics, Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA. pdonohue@jhmi.edu

Pediatrics
|January 12, 2011
PubMed
Summary

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RhD-Positive Blood Product Use in Females of Childbearing Potential: Clarifying Risk and Clinical Context : In reply to O'Brien and colleagues.

Journal of the American College of Surgeons·2026
Same author

Multisite Real-World Validation of an Electronic Health Record-Integrated Generative Artificial Intelligence Tool for Venous Thromboembolism Risk Stratification.

medRxiv : the preprint server for health sciences·2026
Same author

Characterizing parent language about home respiratory technology for children.

Journal of child health care : for professionals working with children in the hospital and community·2026
Same author

Frameworks to identify research gaps, frame research needs, and derive research priorities from evidence syntheses: a scoping review.

Journal of clinical epidemiology·2026
Same author

Pediatric Quality Measures in Vision Screening and Follow-Up.

Pediatrics·2026
Same author

Pediatric Quality Measures in Developmental Screening and Follow-Up.

Pediatrics·2026

Inhaled nitric oxide (iNO) did not reduce mortality or bronchopulmonary dysplasia (BPD) in preterm infants. However, iNO showed a small benefit in reducing the combined outcome of death or BPD.

Area of Science:

  • Neonatal Medicine
  • Respiratory Physiology
  • Clinical Trials

Background:

  • Inhaled nitric oxide (iNO) efficacy for preterm infant respiratory failure is debated.
  • Previous studies yielded variable and contradictory findings.

Purpose of the Study:

  • To systematically review evidence on iNO use in preterm infants (≤34 weeks gestation) receiving respiratory support.
  • To assess iNO's impact on mortality, bronchopulmonary dysplasia (BPD), and neurodevelopmental outcomes.

Main Methods:

  • Comprehensive literature search of multiple databases (Medline, Embase, Cochrane, PsycInfo, ClinicalTrials.gov) and conference proceedings.
  • Inclusion of 14 randomized controlled trials and 8 follow-up/observational studies.
  • Independent data abstraction focusing on mortality, BPD, composite death/BPD, and neurodevelopmental impairment.

Related Experiment Videos

Last Updated: Jun 5, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Main Results:

  • No significant difference in NICU mortality (RR: 0.97) or BPD at 36 weeks (RR: 0.93) between iNO and control groups.
  • A small but significant reduction in the composite outcome of death or BPD (RR: 0.93) was observed with iNO.
  • No evidence of difference in cerebral palsy, overall neurodevelopmental impairment, or cognitive impairment.

Conclusions:

  • iNO demonstrated a 7% reduction in the composite outcome of death or BPD in preterm infants, but not in death or BPD alone.
  • Current evidence does not support routine iNO use in preterm infants with respiratory failure outside of clinical trials.